Rallybio Corporation
NASDAQ:RLYB
0.95 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 24.494 | 56.958 | 175.334 | 140.233 | 19.458 |
| Short Term Investments
| 85.435 | 112.036 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 109.929 | 168.994 | 175.334 | 140.233 | 19.458 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.86 | 19.954 | 10.675 | 2.056 | 2.924 |
| Total Current Assets
| 114.789 | 179.496 | 180.869 | 141.261 | 20.92 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 0.592 | 0.909 | 0.511 | 0.287 | 0.199 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.239 | 0.03 | 0.805 | 0.31 | 0.488 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0.831 | 0.939 | 1.316 | 0.597 | 0.687 |
| Total Assets
| 115.62 | 180.435 | 182.185 | 141.858 | 21.607 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 0.976 | 1.114 | 0.603 | 1.579 | 0.857 |
| Short Term Debt
| 0.438 | 0.362 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 7.849 | 9.268 | 5.948 | 4.264 | 2.949 |
| Total Current Liabilities
| 9.263 | 10.744 | 6.551 | 5.843 | 3.806 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0.173 | 0.748 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -0.374 | 0.032 | 182.039 | 38.082 |
| Total Non-Current Liabilities
| 0.173 | 0.374 | 0.032 | 182.039 | 38.082 |
| Total Liabilities
| 9.436 | 11.118 | 6.583 | 187.882 | 41.888 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 182.027 | 37.141 |
| Common Stock
| 0.004 | 0.004 | 0.003 | 0.99 | 0.286 |
| Retained Earnings
| -235.245 | -160.681 | -94.027 | -47.014 | -20.567 |
| Accumulated Other Comprehensive Income/Loss
| 0.015 | -0.214 | 0 | -230.031 | -57.994 |
| Other Total Stockholders Equity
| 341.41 | 330.208 | 269.626 | 183.015 | 41.134 |
| Total Shareholders Equity
| 106.184 | 169.317 | 175.602 | -47.014 | -20.567 |
| Total Equity
| 106.184 | 169.317 | 175.602 | -47.014 | -20.567 |
| Total Liabilities & Shareholders Equity
| 115.62 | 180.435 | 182.185 | 187.882 | 41.888 |